SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-034607
Filing Date
2014-05-30
Accepted
2014-05-30 16:01:10
Documents
2
Period of Report
2014-05-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v379887_8k.htm 8-K 18979
2 EXHIBIT 99.1 v379887_ex99-1.htm EX-99.1 6990
  Complete submission text file 0001144204-14-034607.txt   27469
Mailing Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 34TH FLOOR NEW YORK NY 10158 646-666-3188
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 208133057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54365 | Film No.: 14880274
SIC: 2836 Biological Products, (No Diagnostic Substances)